International classification of functioning, disability and Health Core Set construction in systemic sclerosis and other rheumatic diseases: A EUSTAR initiative

Rheumatology (United Kingdom)

Volumn 51, Issue 12, 2012, Pages 2170-2176

  Saketkoo, Lesley Ann ^a   Escorpizo, Reuben ^b,c   Keen, Kevin J ^d   Fligelstone, Kim ^e,f   Distler, Oliver ^g  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WHO Collaborating Centre   (Switzerland)

^c UNIVERSITY OF LUCERNE   (Switzerland)

^d UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f The Scleroderma Society   (United Kingdom)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Disability; Functioning; Health economics; ICF; Scleroderma; Systemic sclerosis; WHO

Indexed keywords

ARTICLE; DISEASE CLASSIFICATION; FEASIBILITY STUDY; FUNDING; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; MEDICAL DECISION MAKING; PATIENT CARE; PRIORITY JOURNAL; RECORDING; RHEUMATIC DISEASE; SYSTEMIC SCLEROSIS; WORLD HEALTH ORGANIZATION;

DISABILITY EVALUATION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; RHEUMATIC DISEASES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 84870348677     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes185     Document Type: Article

References (21)

1. World Health Organization. International Classification of Functioning, Disability and Health: ICF. Geneva, Switzerland: WHO, 2001.
2. World Health Organization website. http://www.who.int/classifications/icf/appareas/en/index.html (9 July 2011, date last accessed).
3. Engel GI. The need for a new medical model: a challenge for biomedicine. Science 1977;196:129-36.
4. Grill E, Stucki G. Criteria for validating comprehensive ICF core sets and validating ICF brief core sets. J Rehabil Med 2011;43:87-91.
5. Schwarzkopf SR, Ewert T, Dreinhofer KE, Cieza A, Stucki G. Towards an ICF core set for chronic musculoskeletal conditions: commonalities across ICF core sets for osteoarthritis, rheumatoid arthritis, osteoporosis, low back pain and chronic widespread pain. Clin Rheumatol 2008;27:1355-61.
6. Brockow T, Cieza A, Kuhlow H et al. Identifying the concepts in outcome measures of clinical trials on musculoskeletal disorders and chronic wide spread pain using the International Classification of Functioning, Disability and Health as a reference. J Rehabil Med 2004;44:30-6.
7. Ewert T, Fuessl M, Cieza A et al. Identification of the most common patient problems in patients with chronic conditions using the ICF checklist. J Rehabil Med 2004;44:22-9.
8. ICF Checklist. Geneva, Switzerland: WHO, September 2003.
9. Holper L, Coenen M, Weise A et al. Characterization of functioning in multiple sclerosis using the ICF. J Neurol 2010;257:103-13.
10. Coenen M, Cieza A, Freeman J et al. The development of ICF core sets for multiple sclerosis: results of the International Consensus Conference. J Neurol 2011;258: 1477-88; s00415-011-5963-7.
11. Rauch A, Kirchberger I, Cieza A et al. Does the Comprehensive International Classification of Functioning, Disability and Health (ICF) core set for rheumatoid arthritis capture the nursing practice? A Delphi survey. Int J Nurs Stud 2009;46:1320-34.
12. Cieza A, Geyh S, Chatterji S et al. ICF linking rules: an update lesson based on lessons learned. J Rehabil Med 2005;37:212-8.
13. Gebhardt C, Kirchberger I, Stucki G et al. Validation of the comprehensive ICF core set for rheumatoid arthritis: the perspective of physicians. J Rehabil Med 2010;42: 780-8.
14. Boonen A, Braun J, van der Horst Bruinsma IE et al. ASAS/WHO ICF core sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis 2010;69: 102-7.
15. Stucki G, Cieza A, Geyh S et al. ICF core sets for rheumatoid arthritis. J Rehabil Med 2004;36:87-93.
16. Stucki G, Cieza A. International Classification of Functioning, Disability and Health (ICF) core sets for rheumatoid arthritis: a way to specify functioning. Ann Rheum Dis 2004;63(Suppl II):ii40-45.
17. Sigl T, Cieza A, van der Heijde D, Stucki G. ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis. Ann Rheum Dis 2005;64:1576-81.
18. Saketkoo LA, Escorpizo R, Keen KJ, Fligelstone K, Distler O. Preliminary steps to a health index for systemic sclerosis based on the World Health Organization's (WHO) International Classification of Functioning, Disability and Health (ICF): A European League Against Rheumatism Scleroderma Trials and Research Initiative. In: American College of Rheumatology Annual Scientific Meeting. Chicago, IL, 2011:679.
19. Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer 2009;45:347-53.
20. Kirwan JR, Newman S, Tugwell PS, Wells GA. Patient perspective on outcomes in rheumatology- a position paper for OMERACT 9. J Rheumatol 2009;36:2067-70.
21. Speight J, Barendse SM. FDA guidance on patient reported outcomes. BMJ 2010;340:c2921.